BUSINESSThe Marijuana Herald
Two-year registry study tracks medical cannabis outcomes for PTSD
A UK registry study of 446 patients found sustained improvements in PTSD, anxiety, sleep and quality-of-life measures over two years, with adverse events reported by 16.8 percent. Oklahoma medical businesses should view the findings as useful real-world evidence, not proof of causation, because the study lacked a control group and had substantial missing follow-up data.
Published Nov 12, 2026
Read the full article at The Marijuana Herald#national#research#medical-cannabis#ptsd
Read the original source
Leafy summaries provide industry context. Confirm details with The Marijuana Herald.